Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: Clinical and prognostic significance

Cancer Science

Volumn 99, Issue 10, 2008, Pages 1984-1991

  Sinha, Satyabrata ^a   Singh, Ratnesh K ^b   Alam, Neyaz ^a   Roy, Anup ^c   Roychoudhury, Susanta ^d   Panda, Chinmay Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b West Virginia University Eye Institute   (United States)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA9 INTEGRIN; BETA1 INTEGRIN; MESSENGER RNA; PROTEIN APRG1; PROTEIN HYA22; PROTEIN MLH1; PROTEIN RBSP3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 3P; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MAPPING; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE OF ONSET; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DNA; FEMALE; HUMANS; INDIA; MICRODISSECTION; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS;

EID: 54949109792     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00952.x     Document Type: Article

References (40)

1. Alberg AJ, Lam AP, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 1999; 11: 435-41.
2. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: The first report of the Kolkata cancer registry. Int J Cancer 2002; 100: 86-91.
3. Saxena S, Chakraborty A, Kaushal M et al. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 2006; 7: 75.
4. Albain KS, Allred DC, Clark GM. Breast cancer outcome and predictors of outcome: Are there age differentials? J Natl Cancer Inst Monogr 1994; 16: 35-42.
5. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996; 77: 97-103.
6. Chunder N, Mandal S, Basu D, Roy A, Roychoudhury S, Panda CK. Deletion mapping of chromosome 1 in early onset and late onset breast tumors - a comparative study in eastern India. Pathol Res Pract 2003; 199: 313-21.
7. Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: Association with cyclin D1 amplification and survival. Diagn Mol Pathol 2004; 13: 172-82.
8. Foo CS, Su D, Chong CK et al. Breast cancer in young Asian women: Study on survival. ANZ J Surg 2005; 75: 566-72.
9. Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors. Ann Surg Oncol 2004; 11: 1045-55.
10. Sinha S, Chunder N, Mukherjee N et al. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 2008; 15: 1070-80.
11. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997; 71: 27-92.
12. Fullwood P, Marchini S, Rader JS et al. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res 1999; 59: 4662-7.
13. Maitra A, Wistuba II, Washington C et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001; 159: 119-30.
14. Wistuba II, Montellano FD, Milchgrub S et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997; 57: 3154-8.
15. Wistuba II, Behrens C, Milchgrub S et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18: 643-50.
16. Wistuba II, Behrens C, Virmani AK et al. High resolution chromosome 3p allelotyping of lung cancer and preneoplastic bronchial epithelium reveals multiple sites of 3p allele loss and frequent breakpoints in the 600.kb 3p21.3 region. Cancer Res 2000; 60: 1949-60.
17. Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Chromosome 3p and breast cancer. J Hum Genet 2002; 47: 453-9.
18. Stone JG, Coleman G, Gusterson B et al. Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett 2001; 167: 171-4.
19. Murata H, Khattar NH, Kang Y, Gu L, Li GM. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene 2002; 21: 5696-703.
20. Murata H, Khattar NH, Gu L, Li GM. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 2005; 223: 143-50.
21. Seitz S, Wassmuth P, Plaschke J et al. Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer 2003; 37: 29-35.
22. Viswanathan M, Solomon SP, Tsuchida N, Selvam GS, Shanmugam G. Methylation of E-cadherin and hMLH1 genes in Indian sporadic breast carcinomas. Indian J Exp Biol 2006; 44: 115-9.
23. Naqvi RA, Hussain A, Deo SS et al. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women. Hum Pathol 2008 [Epub ahead of print].
24. Duriseti S, Winnard PT Jr, Mironchik Y, Vesuna F, Raman A, Raman V. HOXA5 regulates hMLH1 expression in breast cancer cells. Neoplasia 2006; 8: 250-8.
25. Leris AC, Roberts TR, Jiang WG, Newbold RF, Mokbel K. Evidence for a tumour suppressive function of APRG1 in breast cancer. Breast Cancer Res Treat 2005; 93: 97-100.
26. Häkkinen L, Kainulainen T, Salo T, Grenman R, Larjava H. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999; 5: 210-7.
27. Kashuba VI, Li J, Wang F et al. RBSP3/HYA22 (RBSP3/HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci USA 2004; 101: 4906-11.
28. Yeo M, Lin PS, Dahmus ME, Gill GN. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J Biol Chem 2003; 78: 6078-85.
29. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors, 6th edn. New.York: Wiley, 2002.
30. Dasgupta S, Mukherjee N, Roy S et al. Mapping of candidate tumor suppressor genes'loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol 2002; 38: 6-15.
31. Tripathi Bhar A, Banerjee S, Chunder N et al. Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Can Res Clin Oncol 2003; 129: 642-50.
32. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. Deregulation of the p14ARF/MDM2/p53 Pathway Is a Prerequisite for Human Astrocytic Gliomas with G1-S Transition Control Gene Abnormalities. Cancer Res 2000; 60: 417-24.
33. Loginov VI, Maliukova AV, Seregin IuA et al. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol Biol 2004; 38: 549-60.
34. Ivanova T, Petrenko A, Gritsko T et al. Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer. BMC Cancer 2002; 2: 4.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402 -8.
36. Köster F, Schröer A, Fischer D, Horn AK, Diedrich K, Friedrich M. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer. Oncol Rep 2007; 17: 1223-7.
37. Bhattacharya N, Chunder N, Basu D et al. Three discrete areas within the chromosomal 8p21.3-23 region are associated with the development of breast carcinoma of Indian patients. Exp Mol Pathol 2004; 76: 264-71.
38. Protopopov A, Kashuba V, Zabarovska VI et al. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 2003; 63: 404-12.
39. Senchenko VN, Liu J, Loginov W et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004; 23: 5719-28.
40. Shu J, Jelinek J, Chang H et al. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res 2006; 66: 5077-84.